Navigation Links
American Legion Anticipates Institute of Medicine Report on Gulf War Veterans
Date:11/14/2007

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- The American Legion welcomes the findings of an Institute of Medicine (IOM) report on Deployment Related Stress scheduled to be released on Nov 14.

"In view of the serious and widespread impact of stress on the health of military personnel who have served in Iraq and Afghanistan, this focus on the health effects of stress is timely and important," said Marty Conatser, national commander of the 2.7 million-member American Legion. "However, it is equally important to distinguish between current deployments and the 1991 Gulf War."

The environmental conditions of the 1991 Gulf War were different from other wars, including current conflicts in Iraq and Afghanistan. Troops serving in the current Iraq war have been subject to long deployments, and many have experienced serious injuries and psychological trauma. A significant number have been affected by long-term psychological problems, most prominently post-traumatic stress disorder (PTSD).

In contrast, the 1991 Gulf War was brief -- just 100 hours of ground fighting -- with remarkably few casualties. Most troops were not in combat areas and did not experience serious trauma. As a result, relatively few were affected by PTSD or other psychiatric conditions.

The 1991 Gulf War gave rise to a different type of health problem, however. About 25 percent of Gulf War veterans have been affected by the condition known as Gulf War veterans' illness. It is a complex of multiple physical symptoms -- typically including chronic headaches, memory problems, widespread pain, and other abnormalities -- that cannot be explained by familiar diagnoses. This condition appears to be unique to Gulf War service; it has not been documented in studies of veterans who served in Bosnia or the current Iraq War.

Consistent findings from multiple research studies indicate that Gulf War illness is not the result of combat or psychological factors, as some have stat
'/>"/>

SOURCE American Legion
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Aspirin Named 8th World Wonder by Majority of Americans
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)... 15 /- Medivation, Inc.,(Na...going Phase 1-2 clinical,trial of its novel androg...,in an oral presentation at the 44th American Soci...Chicago., Session title: New Targeted Strategie...and time: Monday, June 2 at 11:30 a.m. Central Tim...
(Date:5/15/2008)...ia, May 15 /- Cytopia Limit...r its upcoming oral,presentation on CYT997 at the ...nical Oncology (ASCO) will be accessible to the pu...om 9pm on Thursday 15 May (US EDT)., The oral pre... a novel,cytotoxic and vascular disrupting agent, ...
(Date:5/15/2008)... May 15 /- Sanofi-aventis,(...findings from the,landmark ATHENA study showed Mul...treatment of patients with atrial fibrillation or ...ar hospitalizations or death from any,cause by a s...ng the study,primary endpoint. The ATHENA results ...
(Date:5/15/2008)...Newswire/ -- CenterWatch, a publishing and,informa...bout clinical,trials, finds that investigative sit...data capture) systems. More than 75% of respondent...ey had been trained on three or more,EDC systems. ...veness of,their EDC training had improved., State...
Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Robbins 26 Myers to Present at Merrill Lynch Growth Industrials Conference December 13 2007 7805 1FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease 7800 1FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease 7800 2Longs Drugs Plans to Become the First Retailer in Hawaii With Walk in Medical Clinics 7795 1Longs Drugs Plans to Become the First Retailer in Hawaii With Walk in Medical Clinics 7795 2Longs Drugs Plans to Become the First Retailer in Hawaii With Walk in Medical Clinics 7795 3Insmed Appoints Dennis M Lanfear to Board Of Directors 2096 1Insmed Appoints Dennis M Lanfear to Board Of Directors 2096 2Insmed Appoints Dennis M Lanfear to Board Of Directors 2096 3
(Date:5/16/2008)...etraQ, the integrated preclinical contract researc...UQ), has attained Good Laboratory Practice (GLP) r...fying rigorous internationally-benchmarked criteri...onal Association of Testing Authorities (NATA) for...l as GLP bioanalytical services, TetraQ can provid...
(Date:5/16/2008)... DELRAY BEACH, Fla., May 16 /PRNewswire-USNewswire...rship with ALERT FM to provide,emergency messaging...RediStat is developing a ground-breaking video com...Emergency Network. The announcements were made,by ...a Governor,s Hurricane,Conference being held in Ft...
(Date:5/16/2008)... NUTLEY, N.J., May 16 /PRNewswire/ -- Barbara Seni...Sales and Marketing Services, was honored by,Execu...the Policy Makers",2008 Awards Dinner. The biennia...w Brunswick, recognized women of professional dist... members of boards of directors at major,New Jerse...
(Date:5/16/2008)...st and Only Therapy Approved to Treat Both Type 2 ... Cholesterol Welchol Recently Added ...PRNewswire/ -- Daiichi Sankyo, Inc. (DSI),announce... demonstrate that,Welchol(TM) (colesevelam HCl), i...ed therapy, significantly lowers blood glucose (as...
Breaking Medicine News(10 mins):Health News:TetraQ recognized for toxicology services 2Health News:RediStat Corporation Partners With ALERT FM for Disaster-Proof Emergency Communications 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 2Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 3Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 4Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 5Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 6Health News:Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 7
...d flu dogs at Amsterdam's Schiphol airport to chec...e authorities said Saturday. The dogs, German sh...flights from countries where the bird flu virus ha..., Egypt, Russia and Turkey, the Dutch ministry of ...
...r sister, five of her aunts, one great, great aunt...ited States has just found out that "the beast" ha...the middle of the M25 waiting for a lorry to hit m...s an upmarket clothes shop in Chelsea in England. ...
...aturday after violence marred a Gay Pride march th... Organisers said more than 20 marchers had been th...were hurt, with two needing medical treatment," Ma...organisers, told AFP. Italian senator Gianpaolo S...
...pulation without pre-existing cardiovascular disea...r the age of 75 in Britain at high risk of develop...res have suggested, but the researchers believe th...UK and will help minimise health inequalities.A ne...
Other Medicine News:Health News:British Woman Who Has inherited Breast Cancer Wants to Spread Awareness 2Health News:British Woman Who Has inherited Breast Cancer Wants to Spread Awareness 3Health News:British Woman Who Has inherited Breast Cancer Wants to Spread Awareness 4Health News:An Accurate Score to Measure Heart Risk 2Health News:An Accurate Score to Measure Heart Risk 3
The TS100-F trinocular model comes with a photo port that accepts Nikon's FX-III series photomicrographic systems, CCTV camera, or digital camera.
The new Eclipse TS100 is an innovative and efficient inverted routine microscope. This high quality tool complements any research facility. Improved mechanics and increased stability - Nikon has deve
Surgical drill bits, twist drills, HSS. Available in various sizes.
...t change in the difficulty score for each of the 1...sual acuity examinations of 7420 eyes during the E...were derived from the examination of 234 eyes. In ...ch resulted in the ultimate homogeneity of difficu...
Medicine Products: